Pharmacokinetic and Pharmacodynamic Comparability Study of Moxetumomab Pasudotox, an Immunotoxin Targeting CD22, in Cynomolgus Monkeys-Reference-Cited by-同舟云学术

Pharmacokinetic and Pharmacodynamic Comparability Study of Moxetumomab Pasudotox, an Immunotoxin Targeting CD22, in Cynomolgus Monkeys

Published:2013-01 Issue:1 Volume:102 Page:250-261
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Wang Bing,Liang Meina,Yao Zhenling,Vainshtein Inna,Lee Rozanne,Schneider Amy,Zusmanovich Mikhail,Jin Feng,O'Connor Kamille,Donato-Weinstein Bettina,Iciek Laurie,Lavallee Theresa,Roskos Lorin

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference25 articles.

1. Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies;Putnam;Trends Biotechnol,2009

2. Guideline on comparability of biotechnology-derived medicinal products after a change in the manufacturing process, non-clinical and clinical issues,2007

3. Guidance concerning demonstration of comparability of human biological products, including therapeutic biotechnology-derived products,1996

4. Immunotoxin treatment of cancer;Pastan;Annu Rev Med,2007

5. cDNA cloning of the B cell membrane protein CD22: A mediator of B–B cell interactions;Wilson;J Exp Med,1991

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies;Pharmaceutics;2022-04-30

2. Recent advances in microbial toxin-related strategies to combat cancer;Seminars in Cancer Biology;2021-07

3. Critical Issues in the Development of Immunotoxins for Anticancer Therapy;Journal of Pharmaceutical Sciences;2020-01

4. Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia;Frontiers in Immunology;2019-12-20

5. Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties;mAbs;2018-12-17